Red Orbit (Free subscription) | yesterday
ADVISORY, July 25, 2008 (PRIME NEWSWIRE) -- What: Michael Osso, Executive Director of The Leukemia & Lymphoma Society, NYC Chapter will preside over the Opening Bell.
The Detroit Tiger Weblog (Free subscription) | yesterday
The folks over at WDFN have been good friends to this blog, with several on-air mentions by Jamie Samuelson and Sean Baligian has even been kind enough to have me on air. So I’d like to you to one of the stations great annual traditions, the Stoney and Wojo Radiothon. It’s 28 non-stop [...]
Detroit Free Press (Free subscription) | 16 hours ago
U.S. District Judge Bernard Friedman was facing bleak odds a year ago when he was diagnosed with mantle cell lymphoma, a rare and deadly form of cancer. But after months of aggressive chemotherapy and a bone-marrow transplant, the 64-year-old chief judge of U.S. District Court in Detroit is back at work, optimistic about the future and determined to beat an old nemesis.
Science Friday (Free subscription) | 23 hours ago
Researchers report that they've been able to use tobacco plants as biological factories to manufacture specialized proteins needed for an experimental individualized cancer therapy. The researchers are studying a potentially fatal form of non-Hodgkin's lymphoma.
Kukla's Korner (Free subscription) | yesterday
The 11th Annual Stoney and Wojo Radiothon for the Leukemia and Lymphoma Society started today and runs through 7pm on Friday, July 25. Over the past 10 years they’ve raised well over one million dollars toward kicking Leukemia and Lymphoma’s ass! Stoney & Wojo of WDFN in Detroit are broadcasting live for 28 hours straight to raise money for Leukemia & Lymphoma research. During the event, Stoney and...
The Wayne Fontes Experience (Free subscription) | 07/24/2008
Just wanted to pass along that good friend of TWFE, Sports Radio 1130 WDFN, is now broadcasting their 11th Annual Stoney and Wojo Radiothon for the Leukemia and Lymphoma Society. Head to WDFN.com to stream their feed, and to check out the auctions. I often rag on the local sports talk hosts in town, deservedly so, but this is one case where I have nothing but good things to say. As someone who's had...
Fiercebiotech (Free subscription) | 07/24/2008
A new cancer vaccine made from genetically engineered tobacco leaves has been found safe in a small, early-stage trial. The vaccine also spurred the immune systems of 11 out of 16 volunteers in the trial to attack non-Hodgkin's lymphoma, setting it up for a larger trial to help determine whether the therapy should become a key supplement to chemotherapy. FierceVaccines
Sumer's Radiology Site (Free subscription) | 07/24/2008
This is a 58year old known case of NHL presented with right sided weakness. MRI showed hypointense areas in the midbrain and thalamocapsular region with hyperintense appearance on FLAIR with areas of hypointensity. There is evidence of homogenous post gadolinium enhancement and few areas of diffusion restriction on DWI suggesting cellularity. Diagnosis of CNS involvement of systemic lymphoma was made....
Medical,Health News and Articles (Free subscription) | 07/23/2008
In an ironic twist to the relationship between tobacco and human health, it would seem that the future of the plant may lie in growing vaccines against cancer. Researchers in the US took antibodies from patients with a type of lymphoma, grew them in tobacco plants, extracted them, and reinjected the individualized vaccines back [...]
Thaindian News (Free subscription) | 07/23/2008
Washington, July 23 (IANS) US scientists have used the tobacco plant to “grow” key components of a vaccine against lymphoma - a form of cancer. Researchers from Stanford University in California are using the plants as factories for an antibody chemical specific to the cells that cause follicular B-cell lymphoma, BBC News reported Wednesday. These antibodies [...]
The Portland Business Journal (Free subscription) | 07/22/2008
Steven Hooker, senior vice president and chief financial officer for Regence BlueCross BlueShield in Portland, has been elected chair of The Leukemia & Lymphoma Society Board of Directors, effective July 1.
Scientific American (Free subscription) | 07/22/2008
In the first human trial of its kind, a vaccine grown in genetically engineered tobacco plants has proved to be safe, paving the way to one day use it to help combat a potentially fatal form of non-Hodgkin's lymphoma. [More]
Medical News Today (Free subscription) | 07/22/2008
In an ironic twist to the relationship between tobacco and human health, it would seem that the future of the plant may lie in growing vaccines against cancer. Researchers in the US took antibodies from patients with a type of lymphoma, grew them in genetically modified tobacco plants, extracted them, and reinjected the individualized vaccines back into the patients, where in most cases it produced...
bioethics.com (Free subscription) | 07/22/2008
A team of researchers has completed human tests of the first plant-produced vaccine for non-Hodgkin’s lymphoma. The successful results of a phase I clinical trial suggest that plants could provide a safe, inexpensive reservoir to “grow” vaccines for the common human cancer, according to a study published tomorrow (July 22) in the Proceedings of [...]
dooce (Free subscription) | 07/22/2008
Jon and I returned home late yesterday after spending most of the day waiting around at San Francisco International Airport for a flight that was delayed multiple times. Today we're going to the funeral of a very dear loved one (no, not my stepfather, his chemotherapy treatments for lymphoma are going really well and the prognosis looks good, thank you for the prayers and thoughts you have sent me,...
The 2 the latest comments published by users on Lymphoma :
rupali | 12/24/2007
Introduction Non-Hodgkin's lymphoma (NHL) is the most common hematological malignancy and is comprised of around 30 different disease subtypes. Each of these present with a distinct set histological, genetic and clinical characteristics. Treatment options in NHL include chemotherapy, targeted therapies, stem cell transplantation and radiotherapy. Scope of this report NHL background and epidemiology,...
sunilnair | 12/24/2007
Stakeholder Opinions: Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success? Introduction Non-Hodgkin's lymphoma (NHL) is the most common hematological malignancy and is comprised of around 30 different disease subtypes. Each of these present with a distinct set histological, genetic and clinical characteristics. Treatment options in NHL include chemotherapy, targeted therapies, stem...
